Oxitropium

DB12086

small molecule investigational

Deskripsi

Oxitropium has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

Struktur Molekul 2D

Berat 332.419
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

516 Data
Aclidinium The risk or severity of adverse effects can be increased when Oxitropium is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Oxitropium.
Mirabegron The risk or severity of urinary retention can be increased when Oxitropium is combined with Mirabegron.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxitropium.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Oxitropium.
Tiotropium The risk or severity of adverse effects can be increased when Oxitropium is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Oxitropium is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Oxitropium is combined with Umeclidinium.
Glycopyrronium The risk or severity of adverse effects can be increased when Oxitropium is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Oxitropium is combined with Botulinum toxin type A.
Glucagon Oxitropium may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Oxitropium may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Oxitropium is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Oxitropium is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Oxitropium is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Oxitropium is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Oxitropium is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Oxitropium is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Oxitropium is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Oxitropium is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Oxitropium is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Oxitropium is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Oxitropium is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Oxitropium is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Oxitropium is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Oxitropium is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Oxitropium is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Oxitropium is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Oxitropium is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Oxitropium is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Oxitropium is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Oxitropium is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Oxitropium is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Oxitropium is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Oxitropium is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Oxitropium is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Oxitropium is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Oxitropium is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Oxitropium is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Oxitropium is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Oxitropium is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Oxitropium is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Oxitropium is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Oxitropium is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Oxitropium is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Oxitropium is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Oxitropium is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Oxitropium is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Oxitropium is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Oxitropium is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Oxitropium is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Oxitropium is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Oxitropium is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Oxitropium is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Oxitropium is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Oxitropium is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Oxitropium is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Oxitropium.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxitropium.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Oxitropium.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Oxitropium.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Oxitropium.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Oxitropium.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Oxitropium.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxitropium.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Oxitropium.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxitropium.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Oxitropium.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Oxitropium.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Oxitropium.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Oxitropium.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Oxitropium.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Oxitropium.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Oxitropium.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Oxitropium.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Oxitropium.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Oxitropium.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Oxitropium.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Oxitropium.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Oxitropium.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Oxitropium.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Oxitropium.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Oxitropium.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Oxitropium.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Oxitropium.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Oxitropium.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Oxitropium.
Tolterodine The risk or severity of adverse effects can be increased when Tolterodine is combined with Oxitropium.
Oxybutynin The risk or severity of adverse effects can be increased when Oxybutynin is combined with Oxitropium.
Pentolinium The risk or severity of adverse effects can be increased when Pentolinium is combined with Oxitropium.
Trimethaphan The risk or severity of adverse effects can be increased when Trimethaphan is combined with Oxitropium.

Target Protein

Muscarinic acetylcholine receptor M5 CHRM5

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul